Weaker expectations for the oil & gas business
07/11/19 -"This led to an impairment (92% for goodwill) on the former Rhodia and Chemlogics activities (Novecare – Advance Formulations), which damaged the Q3 figures and came fully out of the blue. In ..."
Pages
64
Language
English
Published on
07/11/19
You may also be interested by these reports :
07/08/26
Q2 2026 results from Lanxess failed to impress investors, as the share price dipped ~5% at pixel time. We anticipate that a lack of evident pricing ...
06/08/26
SGL Carbon delivered a resilient first-half performance despite a difficult industrial environment. Sales declined 13% YoY due to the restructuring ...
06/08/26
The decline in the target price is due to changes made to the peer group for Umicore, apart from updates to earnings estimates (discussed below). We ...
03/08/26
Umicore posted strong results for H1 2026, driven by market share gains in Catalysis and a metals rally in Q1. However, we see a repeat of H1 in the ...